← Back to Clinical Trials
Recruiting NCT07609134

NCT07609134 The Development of the Walsh Asthma Self-management Programme and Feasibility of Implementation in Adults With Asthma in Primary Care

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07609134
Status Recruiting
Phase
Sponsor Royal College of Surgeons, Ireland
Condition Asthma
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2026-05
Primary Completion 2027-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
WASP asthma self-management programme

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2026-05 with a primary completion date of 2027-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Asthma is a common medical condition in Ireland. Adult patients tend to have periods when their asthma is stable and periods when it worsens. In order to reduce these periods of worsening asthma, effective ongoing management is required day to day by adults with asthma. Teaching adults how to manage their asthma effectively, plays a huge role in improving their asthma and having a better overall quality of life. This education on managing asthma has many different parts to it. Most adults will discover they have asthma through their general practitioner (GP) and it will be continued to be checked and managed through their GP or general practice nurse (GPN) in their primary care clinic for the duration of their lives. This research study is taking place to find out if a new education programme, will help adults manage their asthma better and improve the symptoms of asthma, reducing its overall impact on day-to-day life. This study is also looking at how easy it is to introduce and for nurses to deliver this study within a GP/ primary care centre. This study is to find out if this education programme works in a real life setting and if it can lead to better control of asthma for adults.

Eligibility Criteria

Inclusion Criteria: * Adults over 18 years old * Adults who meet one of the following criteria: a physician's diagnosis of asthma; coded as asthma (R96) as per the international classification of primary care (ICPC) or international classification of diseases (ICD) code J45 with associated use of asthma medications for 6 months prior to study enrolment. Exclusion Criteria: * Adults under 18 years old * Adults with no diagnosis of asthma * Adults receiving asthma education in a specialist hospital or community setting * Adults unable to give informed consent * Smoking ≥ 10 Pack Year History

Contact & Investigator

Central Contact

Joanne Walsh, MSc

✉ joannewalsh21@rcsi.com

📞 01-4022300

Frequently Asked Questions

Who can join the NCT07609134 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Asthma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07609134 currently recruiting?

Yes, NCT07609134 is actively recruiting participants. Contact the research team at joannewalsh21@rcsi.com for enrollment information.

Where is the NCT07609134 trial being conducted?

This trial is being conducted at Dublin, Ireland.

Who is sponsoring the NCT07609134 clinical trial?

NCT07609134 is sponsored by Royal College of Surgeons, Ireland. The trial plans to enroll 40 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology